Lynparza and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with Lynparza (olaparib).
Caffeine Olaparib
Moderate Drug Interaction
Olaparib may decrease the blood levels and effects of caffeine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your symptoms worsen or your condition changes during treatment with these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Olaparib Food
Major Food Interaction
Do not consume grapefruit, grapefruit juice, or Seville oranges during treatment with olaparib. Doing so can significantly increase the blood levels of olaparib and increase the risk and/or severity of side effects such as nausea, vomiting, diarrhea, indigestion, loss of appetite, abdominal pain or discomfort, lung problems, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Switch to professional interaction data
Lynparza drug interactions
There are 631 drug interactions with Lynparza (olaparib).
Lynparza disease interactions
There are 4 disease interactions with Lynparza (olaparib) which include:
More about Lynparza (olaparib)
- Lynparza consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Anastrozole
Anastrozole systemic is used for breast cancer, breast cancer, metastatic, endometrial cancer ...
Letrozole
Letrozole systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Tamoxifen
Tamoxifen blocks the actions of estrogen and is used to treat and prevent some types of breast ...
Estradiol
Estradiol is used to treat symptoms of menopause such as hot flashes, and vaginal dryness, burning ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.